Health Care: Drugs

Trinity Biotech PLC (TRIB: NASDAQ)

$23 -0.1 | -0.43%
07/28/14 - 11:35 AM ET
Company Cash Flow
Dec 2013 Dec 2012 Dec 2011 Dec 2010
Cash Flow From Operating Activities
Net Income (Loss) 9.65M 17.34M 15.59M 60.42M
Operating Gains/Losses 1.00K -55.00K -10.00K -46.41M
Extraordinary Gains / Losses 0.00 0.00 0.00 0.00
(Increase) Decrease In Receivables -7.03M -2.06M 1.28M 3.09M
(Increase) Decrease in Inventories -7.26M -1.37M -2.41M -2.83M
(Increase) Decrease In Other Current Assets 0.00 0.00 0.00 0.00
(Decrease) Increase In Payables 3.26M 22.00K -33.00K 1.57M
(Decrease) Increase In Other Current Liabilities 0.00 0.00 0.00 0.00
(Increase) Decrease In Other Working Capital 0.00 0.00 0.00 0.00
Other Non-Cash Items 7.16M 3.26M 3.45M 4.41M
Net Cash From Continuing Operations 9.36M 19.96M 20.46M 23.07M
Net Cash From Discontinued Operations 0.00 0.00 0.00 0.00
Cash Provided By Investing Activities
Net Cash From Total Operating Activities 9.36M 19.96M 20.46M 23.07M
Sale of Property, Plant & Equipment 0.00 0.00 0.00 16.00K
Cash Used for Investing Activities
Sale of Short-Term Investments 0.00 0.00 0.00 0.00
Purchases of Property, Plant & Equipment -23.18M -15.30M -9.24M -9.02M
Acquisitions -38.02M -5.91M -2.14M 0.00
Purchases of Short-Term Investments 0.00 0.00 0.00 0.00
Other Cash from Investing Activities 0.00 0.00 0.00 65.89M
Cash Provided by Financing Activities
Net Cash From Investing Activities -61.19M -9.96M -130.00K 56.88M
Issuance of Debt 0.00 0.00 0.00 1.48M
Cash Used for Financing Activities
Issuance of Capital Stock 3.66M 2.50M 1.19M 1.02M
Repayment of Long-Term Debt 0.00 0.00 0.00 -30.41M
Repurchase of Capital Stock 0.00 -5.34M -6.09M 0.00
Payment of Cash Dividends -4.37M -3.22M -2.14M 0.00
Other Financing Charges, Net -87.00K -131.00K -197.00K -74.00K
Net Cash From Financing Activities -798.00K -6.19M -7.25M -27.98M
Effect of Exchange Rate Changes 4.00K 54.00K 4.00K -50.00K
Net Change in Cash & Cash Equivalents -52.63M 3.86M 13.08M 51.92M
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter